NAPOLITANO, FABIANA
 Distribuzione geografica
Continente #
AS - Asia 947
EU - Europa 911
NA - Nord America 581
SA - Sud America 124
AF - Africa 29
OC - Oceania 2
Totale 2.594
Nazione #
US - Stati Uniti d'America 549
SG - Singapore 455
RU - Federazione Russa 398
IT - Italia 300
CN - Cina 238
BR - Brasile 100
DE - Germania 87
HK - Hong Kong 79
VN - Vietnam 74
IN - India 40
NL - Olanda 30
FI - Finlandia 27
FR - Francia 19
CA - Canada 17
KR - Corea 17
GB - Regno Unito 15
CI - Costa d'Avorio 14
AR - Argentina 12
MX - Messico 12
PK - Pakistan 11
ZA - Sudafrica 7
BE - Belgio 6
JP - Giappone 6
PL - Polonia 6
UA - Ucraina 6
EC - Ecuador 5
SE - Svezia 5
ES - Italia 4
ID - Indonesia 4
IQ - Iraq 4
IL - Israele 3
MY - Malesia 3
TR - Turchia 3
VE - Venezuela 3
AT - Austria 2
AU - Australia 2
CL - Cile 2
CZ - Repubblica Ceca 2
PY - Paraguay 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BF - Burkina Faso 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
JO - Giordania 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
ZM - Zambia 1
Totale 2.594
Città #
Singapore 233
Naples 137
Hefei 100
Moscow 83
Hong Kong 79
Ashburn 69
Beijing 58
Santa Clara 49
Dallas 46
Munich 43
Chandler 39
Ho Chi Minh City 33
Kochi 23
San Jose 23
Amsterdam 21
Los Angeles 19
Seoul 17
Turku 16
Hanoi 15
Napoli 15
São Paulo 13
Falkenstein 11
Millbury 10
New York 10
Redondo Beach 10
Boston 9
Buffalo 9
Frankfurt am Main 9
Helsinki 9
Lawrence 9
Pune 9
Seattle 8
Turin 8
Rome 7
The Dalles 7
Toronto 7
Casoria 6
Des Moines 6
Mexico City 6
Milan 6
Ninh Bình 6
Warsaw 6
Brooklyn 5
Lauterbourg 5
Nuremberg 5
Tokyo 5
Brussels 4
Chicago 4
Düsseldorf 4
Formia 4
Fucecchio 4
Houston 4
Johannesburg 4
Lahore 4
London 4
Montreal 4
Poplar 4
Salerno 4
Stockholm 4
Atlanta 3
Baghdad 3
Belo Horizonte 3
Bologna 3
Casagiove 3
Chengdu 3
Guayaquil 3
Islamabad 3
Kuala Lumpur 3
Ottawa 3
Pomigliano d'Arco 3
Pozzuoli 3
Quảng Ngãi 3
Redwood City 3
Afragola 2
Ankara 2
Aurora 2
Boardman 2
Buenos Aires 2
Council Bluffs 2
Da Nang 2
Denver 2
Fairfield 2
Fort Worth 2
Gravataí 2
Harbin 2
Krefeld 2
Lomazzo 2
Lucknow 2
Luco dei Marsi 2
Maceió 2
Maiori 2
Marcianise 2
Muriaé 2
Nanjing 2
Nova Iguaçu 2
Orem 2
Perth 2
Pioltello 2
Pisa 2
Porto Alegre 2
Totale 1.467
Nome #
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 163
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 152
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review. 137
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer 129
Mechanisms of resistance to mTOR inhibitors 127
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules 122
Use of folfirinox or nab-paclitaxel plus gemcitabine for the treatment of locally advanced pancreatic adenocarcinoma: A single institution observational study 122
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations 115
RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges 115
A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer 115
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: a systematic review 114
Role of FGFR3 in bladder cancer: Treatment landscape and future challenges 112
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer 112
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer 112
Tumour microenvironment and immune evasion in EGFR addicted NSCLC: Hurdles and possibilities 108
Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors 106
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma 104
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study 101
EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer 100
Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC 98
Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes 75
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis 72
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer 69
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors 67
Totale 2.647
Categoria #
all - tutte 8.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 12 0 12 4 4 0
2021/202280 0 0 9 7 1 3 3 4 4 7 20 22
2022/2023180 15 10 5 3 19 16 12 20 30 25 14 11
2023/2024190 4 18 43 16 7 32 3 22 6 6 16 17
2024/2025948 28 21 5 17 26 75 90 82 49 138 336 81
2025/20261.151 192 148 251 160 290 82 28 0 0 0 0 0
Totale 2.647